🇺🇸

Index Intelligence

US SEC Filing Intelligence · 1471 digests

New to these filings? Learn what a 13F institutional-holdings report is

· daily

S&P 500 Technology Sector SEC Filings — October 30, 2026

Today's S&P 500 Technology filings present a bifurcated picture: Fortinet delivered a standout Q3 2026 with revenue up 20.5% YoY to $2,078.4M and product revenue surging 36.8%, yet gross margin compressed (product GM 64.4% vs 67.7%) and buyback intensity slowed to $972.8M from $2,232.6M a year ago. Meanwhile, insider activity skews cautious-to-bearish: Texas Instruments director Ronald Kirk sold 6,065 shares at $310.39 (~$1.88M) after exercising options at $79.26, and Datadog CTO Alexis Le-Quoc sold 11,430 shares at $277.30 (~$3.17M) under a 10b5-1 plan amid 11 total transactions. Palantir disclosed three separate stock awards to executives (Taylor, Glazer, Sankar) totaling 987,246 Class A shares, a neutral but dilution-relevant governance signal. The common thread is a sector investing heavily for growth (Fortinet product acceleration, Palantir talent retention via equity) while insiders at mature names monetize gains. Portfolio implication: favor names with accelerating product revenue and disciplined capital returns; monitor insider selling clusters in semis and high-multiple software.

3 high priority 3 medium 6 total filings
· daily

Nasdaq 100 Stocks SEC Filings — October 30, 2026

Across 11 NASDAQ-100 filings, the dominant theme is a widening gap between operating momentum and bottom-line optics: Amazon, Intel, and Gilead all posted strong top-line and/or operating gains that were masked by non-operating items, mark-to-market losses, or acquired IPR&D charges. Amazon's Q3 revenue rose 12.1% YoY to $201.9B with operating income up 61.2% to $28.1B, yet EPS slipped to $1.89 on a $703M non-operating expense versus a $10.2B prior-year gain; capex is running at a $215B trailing-12-month pace, funded by $115.1B of nine-month debt proceeds. Intel delivered 20.9% YoY revenue growth and a swing to $2.5B operating income, but a $12.6B mark-to-market loss on Escrowed Shares drove a nine-month net loss of $11.4B, while Foundry remains loss-making at -$1.85B. Gilead's product sales grew 12.9% but $11.3B of acquired IPR&D and $1.75B of impairments produced a nine-month net loss of $6.0B and cut retained earnings to $3.1B from $13.7B. ADP showed solid 6.1% revenue and 13.7% EPS growth, offset by a $855M unrealized AFS loss that crushed comprehensive income 60.8%. Insider activity skewed negative: sales at CoreWeave (PAO, $392K), Texas Instruments (director, $1.88M), Alphabet (director, $23K), and PayPal (10b5-1, $40.5K), while Palantir issued large equity awards to three executives (987K shares combined) with no open-market purchases. The common thread is elevated capital intensity and non-operating volatility across mega-cap tech and biopharma, with insider conviction tilted toward selling into strength.

6 high priority 5 medium 11 total filings
· daily

S&P 500 Financials Sector SEC Filings — October 30, 2026

The October 30, 2026 S&P 500 Financials filings reveal a sector navigating a mixed operating environment: Bank of America posted solid top-line growth (Q3 revenue +3.2% YoY to $29,958M, NII +8.0%) but suffered a sharp 16.8% YoY net income decline to $6,933M as noninterest expense surged 13.8% and the efficiency ratio deteriorated to 65.83% from 59.70%. Capital markets activity was robust, with American Express issuing $3.0B in senior notes (coupons 5.447%–5.817%) and U.S. Bancorp raising $1.0B via Series P preferred stock, signaling continued balance-sheet optimization and funding diversification. Insider activity was negative: Robinhood Markets sold 124,319 shares (~$3.08M) of Robinhood Ventures Fund I, trimming its stake to 12.92M shares. Truist's 13F-HR disclosed 5,371 positions with a large-cap tilt (Coca-Cola Europacific Partners $479.2M, Eaton $209.8M), offering little actionable signal. Overall, the filings point to margin pressure from elevated operating costs, resilient net interest income, and active capital management, with investors likely to focus on expense discipline and credit trends in upcoming earnings calls.

3 high priority 2 medium 5 total filings
· daily

S&P 500 Energy Sector SEC Filings — October 30, 2026

Q3 2026 earnings from ExxonMobil and Chevron reveal a sector enjoying a powerful YoY upcycle—Exxon YTD earnings surged +$11.8B and Chevron's ROCE more than doubled to 17.7%—yet sequential momentum is already fading as lower realizations, entitlement effects, and Middle East disruptions bite. Exxon's Upstream earnings fell to $7.088B from $7.927B QoQ and Chemical Products dropped to $735M from $1.131B, while Chevron's earnings declined 18% QoQ and production slipped 2.6% YoY to 3,980 MBOED. Capital returns remain the anchor: Exxon declared its 44th consecutive annual dividend increase at $1.07/share, and Chevron held its $1.78/share dividend while cutting leverage (debt-to-CFFO 0.6x vs 1.3x). Portfolio actions are accelerating—Exxon raised working interests in Papua LNG (34%) and Rovuma (50%), and Valero agreed to buy a 700-acre former LyondellBasell refinery site for $320.5M, signaling bet-on-refining capacity. Insider and institutional flows are mixed: SLB's Chief Legal Officer sold ~$1.12M of stock, Kinder Morgan's President gifted shares, and Vanguard disclosed large passive stakes across Exxon (7.62%), Halliburton (5.36%), TPL (5.11%), and SLB (4.97%). Net read: a sector at peak YoY optics but decelerating sequentially, where capital discipline, M&A optionality, and dividend durability are the differentiators.

2 high priority 7 medium 9 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — October 30, 2026

The 9 filings from S&P 500 Consumer Staples constituents reveal a sector navigating a bifurcated demand environment, with organic growth diverging sharply from reported sales due to portfolio actions and foreign exchange. Church & Dwight delivered a standout Q3 with organic sales +5.1% and adjusted EPS +13.6%, yet reported sales grew only 1.0% and Q4 is guided to decline ~0.5% due to 2025 strategic portfolio actions, highlighting the gap between underlying momentum and headline numbers. Colgate-Palmolive posted organic growth of 3.6% and raised full-year EPS guidance to 5-7%, but North America net sales fell 1.7% with volume down 3.7% and operating profit down 11%, signaling regional weakness. Margin expansion was a common theme: Church & Dwight gross margin +170 bps to 46.8% and Colgate +80 bps to 60.2%, driven by cost controls and pricing. However, cash flow trends are mixed: Church & Dwight operating cash flow slipped 1.3% on a $98.2M inventory build, while Colgate's operating cash flow rose 6.1% but comprehensive income fell 9.1% on currency headwinds. Insider activity is absent, but Vanguard's passive stakes (4.61-7.05%) in General Mills, Molson Coors, and Estée Lauder reflect continued institutional interest without control intent. P&G's $4.0B debt offering at coupons up to 5.900% signals a higher-for-longer rate environment, raising the bar for capital allocation. Overall, the sector shows resilient pricing power and margin recovery, but volume pressures and currency headwinds warrant selective exposure.

2 high priority 7 medium 9 total filings
· daily

S&P 500 Industrials Sector SEC Filings — October 30, 2026

The 15 filings in this digest reveal a bifurcated S&P 500 Industrials landscape: defense and aerospace names (General Dynamics) are posting double-digit revenue growth with record backlog, while transportation and business-services names (Republic Services, ADP) are growing mid-single-digits but facing margin and cash-flow pressures. General Dynamics stands out with Q3 2026 revenue +12.9% YoY to $14.6B and EPS +15.7% to $4.49, yet free cash flow fell to $1.2B from $1.9B and Combat Systems margin contracted 110 bps, underscoring execution unevenness. Republic Services grew revenue 8.2% YoY to $4,559M but saw interest expense +9.8% and equity-method losses widen to $48M, while ADP grew revenue 6.1% but suffered a 60.8% collapse in comprehensive income on an $855M unrealized securities loss. Insider activity skews negative: Delta's CEO sold $4.1M, UPS's Chief US Domestic Officer sold $877K, and FedEx's Chief People Officer sold $7.31M across 14 transactions. Parker-Hannifin's eight directors each received 205 RSUs, a routine but broad-based board compensation event. The dominant cross-cutting theme is cash-flow quality and balance-sheet strain (FX translation losses at GD, AOCI widening at ADP, receivables build at Republic) even as top-line growth remains intact.

14 high priority 1 medium 15 total filings
· daily

Dow Jones 30 Stocks SEC Filings — October 30, 2026

The October 30, 2026 filing batch reveals a market defined by aggressive capital deployment and divergent earnings quality among Dow 30 constituents. Amazon's Q3 2026 results show a striking bifurcation: operating income surged 61.2% YoY to $28.1B on services strength, yet net income fell 2.4% as a $10.2B prior-year non-operating gain reversed, while nine-month capex ballooned to $175.7B (vs. $92.3B) and long-term debt proceeds hit $115.1B—signaling a debt-funded AI infrastructure bet that pressures near-term EPS. Chevron posted a massive YoY earnings rebound ($9.9B vs. $3.5B) on $97/bbl Brent and downstream recovery, but sequential earnings fell 18% and production slipped 2.6% YoY, while its balance sheet strengthened (debt-to-CFFO 0.6x vs. 1.3x). Three blue-chip issuers—Amex ($3.0B), P&G ($4.0B), and implicitly Amazon—tapped investment-grade markets, with P&G's curve topping out at 5.900% for 2056 paper, indicating elevated long-end rates. Insider activity was muted and slightly negative: an Alphabet director sold a small 10b5-1 tranche (~$23.3K). Vanguard's 13G in Nike (5.19% passive stake) is routine. Net: a capex-heavy, debt-funded growth cycle in tech contrasts with cash-generative energy and staples, creating relative-value opportunities and duration risk for bond-heavy balance sheets.

1 high priority 5 medium 6 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — October 30, 2026

The six filings reveal a consumer discretionary sector defined by aggressive platform expansion and capital intensity, offset by mixed earnings quality and selective insider selling. Amazon and DoorDash both delivered strong top-line growth (12.1% and 34% YoY, respectively), but Amazon's net income slipped 2.4% due to a prior-year non-operating gain reversal, while DoorDash's net income surged 91% YoY despite rising costs. Capital allocation is shifting toward debt-funded expansion: Amazon raised $115.1B in long-term debt and spent $175.7B on capex in nine months, while GM Financial issued $1.25B in senior notes. Insider activity is a notable negative signal, with Hilton's Kevin Jacobs selling $15.3M in stock after exercising options, suggesting potential valuation concerns. Institutional ownership changes are neutral, with Vanguard's 5.19% passive stake in Nike offering no directional signal. Overall, the sector shows a bifurcation between high-growth platforms investing heavily for future returns and mature companies facing margin pressures and insider distribution.

4 high priority 2 medium 6 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — October 30, 2026

The Q3 2026 healthcare earnings season reveals a sector grappling with patent cliffs, pipeline replenishment costs, and margin pressures, yet punctuated by standout growth stories. Regeneron (REGN) delivered a blowout quarter with revenue up 36.3% YoY to $5.1B, driven by Dupixent and EYLEA HD, but legacy EYLEA U.S. sales plunged 41%, highlighting the franchise transition risk. Gilead (GILD) posted a nine-month net loss of $6.0B due to $11.3B in acquired IPR&D, a stark reminder of the cost of replenishing its pipeline. AbbVie (ABBV) showed resilience with revenue up 10.3% and raised EPS guidance, but Humira and Imbruvica declines underscore its own patent challenges. Thermo Fisher (TMO) continued its steady growth (+9.1% revenue) and aggressive M&A ($8.9B YTD), while Stryker (SYK) saw profitability deteriorate with EPS down 11.7% on impairments and margin compression. Insider activity was mixed: a TMO director gifted shares and a C-level executive sold ~$2M, while Vanguard's passive stake in IDEXX crossed 5%. Overall, the sector faces a bifurcated landscape: innovative biopharma with strong growth but pipeline costs, and medtech with stable growth but margin headwinds.

7 high priority 3 medium 10 total filings
· daily

S&P 500 Technology Sector SEC Filings — October 29, 2026

The October 29, 2026 S&P 500 Technology filings present a bifurcated picture: strong fundamental momentum in semiconductor equipment (KLA) and networking (Cisco), offset by a pronounced wave of insider selling across Texas Instruments, Apple, and CrowdStrike. KLA delivered standout Q1 FY2027 results with revenue up 28.9% YoY to $4.14B, net income up 38.1%, and gross margin expanding ~60 bps to 61.9%, though operating cash flow lagged earnings and inventories swelled 12.1% sequentially. Cisco's FY2026 proxy confirms a record year—revenue $63.3B (+12% YoY), GAAP operating margin up 350 bps to 24.3%, and $12.7B returned to shareholders (99% of FCF)—but the non-GAAP margin improvement was only 40 bps, suggesting adjusted profitability is plateauing. Insider activity is uniformly negative: three Texas Instruments directors sold a combined ~$4.3M, CrowdStrike's CEO sold ~$1.13M across 17 transactions, and Apple's GC sold ~$824K, all under pre-arranged plans but clustering on the same day. The absence of forward guidance in these filings limits catalyst visibility, making the December 15 Cisco annual meeting and the next earnings cycle the key near-term checkpoints. Overall, the digest signals a sector still growing but facing rising insider caution and working-capital pressure at the equipment layer.

6 high priority 2 medium 8 total filings
· daily

Nasdaq 100 Stocks SEC Filings — October 29, 2026

The 21 filings reveal a market bifurcated by AI infrastructure spending: Amazon, Alphabet, and Intel all posted strong top-line growth (12%, 24.6%, and 21% YoY respectively) driven by cloud and data-center demand, but margin and cash-flow pressures are mounting—Amazon swung to a $42.4B TTM free-cash-flow outflow on $94.8B higher capex, and Alphabet's net income fell 24.3% YoY despite 29.9% operating-income growth due to a $21B swing in other income. Guidance is mixed: Amazon projects AWS growth >40% through 2028, Intel guides Q4 revenue down sequentially to $15–16B with GAAP EPS collapsing to $0.10, and Starbucks expects FY2027 revenue to decline ~1% even as comps turn positive. Insider activity skews bearish: three Texas Instruments directors sold a combined ~$4.3M of stock at ~$302, and Apple's GC sold $824K under a 10b5-1 plan, while Netflix's co-CEO gifted shares. Capital allocation remains shareholder-friendly at Cisco (99% of FCF returned) and Linde ($2.6B buybacks), but Gilead's $12.4B IPR&D charge will produce a GAAP loss per share of $(4.40)–$(4.05) for 2026. Across the stream, the dominant pattern is AI-driven revenue acceleration colliding with elevated capex, tax, and compensation costs, creating a wide dispersion in earnings quality.

11 high priority 10 medium 21 total filings
· daily

S&P 500 Financials Sector SEC Filings — October 29, 2026

The 16-filing batch reveals a financials sector bifurcating into transaction/network compounders and asset-gathering businesses under pressure. Mastercard (net revenue +14% YoY, EPS +22%) and ICE (net revenue +15% YoY, adjusted EPS +18%) delivered record quarters, while T. Rowe Price suffered $28.3B net outflows and Coinbase posted a 34.9% YoY revenue decline with a nine-month swing to a $34.9M net loss. Northern Trust was the standout earnings grower (+40% YoY net income, EPS +48%) but its balance sheet contracted 6% and AUC slipped 1% sequentially, signaling the growth was fee- and market-driven rather than organic. Insider activity skews bearish in aggregate (Capital One's CEO sold ~$17M across five transactions, plus sales at Interactive Brokers, Goldman Sachs, Travelers and Robinhood), yet Truist CEO Michael Lyons bought 25,000 shares (~$1.21M) at $48.36 — a high-conviction counter-signal. Capital allocation remains aggressively shareholder-friendly (ICE returned $2.5B YTD including $1.6B buybacks; Mastercard repurchased $12.0B in nine months, shrinking equity to $6.7B), which supports EPS but is compressing balance-sheet buffers and, at Mastercard, driving interest expense up 34.5% YoY. Key catalysts ahead: ICE's MarketAxess acquisition now expected to close Q1 2027 after early HSR termination, and US Bancorp's immediate CRO resignation creates a governance gap to monitor.

13 high priority 3 medium 16 total filings
· daily

S&P 500 Energy Sector SEC Filings — October 29, 2026

The October 29, 2026 digest for the S&P 500 Energy stream contains two filings: a routine board appointment at Marathon Petroleum (MPC) and a sizable insider sale by SLB's Chief Accounting Officer. Neither filing includes financial results, guidance, capital allocation, or transaction data, so period-over-period trend analysis is not possible from this batch. The dominant actionable signal is the SLB insider sale of 10,047 shares at $53.65 (~$539K), which reduced the CAO's holdings to 12,845 shares — implying roughly 44% of his position was sold, a meaningful conviction signal for a non-CEO executive. MPC's election of David E. Constable (effective March 1, 2027) is a governance positive given his CEO experience at Fluor and Sasol and board seats at Anadarko, Rio Tinto, and ABB, but it carries no near-term financial catalyst. Overall, the batch skews neutral-to-cautious: one negative insider signal, one neutral governance update, and no fundamental data to confirm or refute sector earnings momentum. Investors should treat this as a low-information day and focus on the SLB insider pattern and the MPC board transition timeline as the only differentiated items.

2 high priority 2 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — October 29, 2026

The 11 filings from S&P 500 Consumer Staples companies reveal a sector navigating a tug-of-war between price-driven revenue growth and volume declines, with mixed sentiment dominating (6 of 11 filings). Portfolio-level revenue growth averaged ~2.3% YoY, but organic growth was weaker (Hershey +0.8%, Mondelez +2.1%), as volume/mix turned negative at Hershey (-10 points) and flat at Mondelez North America. Margin trends diverged sharply: Hershey's gross margin expanded ~1,350 bps to 46.1% on lower costs and tariff refunds, while Mondelez's SG&A jumped 13.3% YTD, and Altria's operating income growth was flattered by a prior-year impairment. Insider activity was sparse, but capital allocation remained shareholder-friendly: Altria expanded its buyback by $1B, Hershey repurchased $439M in stock and paid $859M in dividends, and Kimberly-Clark priced $4.9B in notes to fund its Kenvue acquisition. Management changes at Clorox (new CEO from Unilever) and Hormel (CEO role expanded) signal strategic shifts, while Church & Dwight added a director with deep consumer goods experience. The most critical developments are Hershey's raised EPS guidance (36-38.5% growth) despite volume weakness, Mondelez's tuck-in acquisition of Undercover Snacks, and Kimberly-Clark's debt-funded Kenvue deal, which will reshape the household products landscape. Overall, the sector faces persistent volume pressure and cost inflation, but strong pricing power, cost controls, and capital returns are supporting earnings.

7 high priority 4 medium 11 total filings
· daily

S&P 500 Industrials Sector SEC Filings — October 29, 2026

The 11 filings reveal a bifurcated industrials landscape: strong top-line growth and record backlogs across HVAC/building solutions (Carrier +12%, Trane +18%, Otis +6%, Republic +8%) and machinery (Caterpillar +17%), but GAAP earnings quality is deteriorating sharply due to one-time items, cost inflation, and separation expenses. Carrier's $3.1B goodwill impairment in Climate Solutions Europe and FedEx Freight's separation costs ($105M vs $30M) exemplify the gap between adjusted and GAAP results. Margin pressure is widespread: Trane's gross margin compressed ~60 bps, Caterpillar absorbed $460M of unfavorable manufacturing costs (freight/tariffs), and Republic's adjusted EPS grew only 2.1% despite 8.2% revenue growth. Insider activity is negative (Johnson Controls director sold $637K), and capital allocation remains shareholder-friendly (Republic's new $5B buyback, Carrier's $1.1B repurchases) but balance sheets are weakening (Carrier equity down 26%, cash down 30% at Trane). Forward guidance is mixed: Republic and FedEx Freight raised revenue/adjusted profit outlooks, while Carrier narrowed EPS and Trane merely reaffirmed. The common thread is a late-cycle environment where pricing and volume are decelerating (Republic yield slowed to 2.9% from 4.0%) and cost headwinds are intensifying, pressuring margins and cash flow.

5 high priority 6 medium 11 total filings
· daily

Dow Jones 30 Stocks SEC Filings — October 29, 2026

Today's Dow 30 filing slate is dominated by Q3 2026 earnings from four mega-cap constituents, and the unifying theme is a stark divergence between operating strength and bottom-line optics. Amazon (net sales +12% YoY to $201.9B, operating income $28.1B at a record 13.9% margin, AWS +39.3% to $46.0B) and Alphabet (revenue +24.6% YoY to $127.6B, operating income +29.9%) both posted exceptional core results, yet each saw net income fall (AMZN -2.4%, GOOGL -24.3%) purely on prior-year investment gains and other-income swings — a reminder that headline EPS is a poor proxy for these franchises this quarter. Caterpillar delivered the cleanest beat-and-raise profile (sales +17%, EPS $7.13 vs $4.88, operating margin 20.4% from 17.3%) despite $460M of combined freight and tariff headwinds, while Merck grew sales 5% and raised full-year guidance but suffered GAAP EPS -12% and severe generic erosion (JANUVIA -39%, LAGEVRIO -88%). Capital intensity is the portfolio-level story: Amazon's TTM free cash flow swung to a -$42.4B outflow on a $94.8B capex increase, and Alphabet's R&D rose 36.2% YoY — AI infrastructure spending is compressing cash conversion across hyperscalers even as margins expand. Insider activity skewed negative with three executive sales (Travelers $1.2M, Apple $824K, Goldman $92.6K), though all were modest relative to holdings and one was a pre-scheduled 10b5-1 plan. Cisco's proxy confirms a record FY2026 ($63.3B revenue, +12%; GAAP EPS +31% to $3.33) with 99% FCF return, setting up a December 15 annual meeting as the next governance catalyst.

4 high priority 6 medium 10 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — October 29, 2026

The 16 filings reveal a consumer discretionary sector grappling with margin pressures and strategic pivots. Chipotle, Ford, and eBay all reported revenue growth but earnings declines due to cost inflation and tax headwinds, while Amazon and DoorDash delivered robust top-line growth but faced profitability nuances. DoorDash's $17B acquisition of Instacart dominated the news, signaling consolidation in delivery, with a long regulatory timeline. Starbucks showed strong comparable sales but revenue fell due to China refranchising, and guidance points to a decline. GM's CAO retirement is immaterial. Overall, companies are investing heavily in growth (Amazon capex, DoorDash M&A) at the expense of near-term margins, and cost pressures are evident in labor and operating expenses. The sector faces a mixed outlook with selective opportunities in companies with strong execution and strategic clarity.

12 high priority 4 medium 16 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — October 29, 2026

Q3 2026 S&P 500 Healthcare earnings reveal a sector-wide tension: strong top-line growth (Lilly +39%, Gilead +13%, BMS +7%, Merck +5%, Baxter +5%, Stryker +7.7%) is being offset by aggressive acquired IPR&D spending, margin compression, and generic erosion in legacy portfolios. Lilly and Gilead both took massive IPR&D charges ($4.18B and $12.4B respectively) tied to pipeline acquisitions, pushing GAAP EPS into loss territory for Gilead and sharply lowering Lilly's full-year non-GAAP EPS guidance despite a $4.07 underlying increase. Merck, BMS, and Stryker all reported gross margin contractions (Merck -480 bps GAAP, BMS -360 bps, Stryker operating margin -280 bps), driven by product mix, amortization, and one-time charges. Insider activity at Danaher shows two senior executives (EVP and CAO) selling a combined ~$4.7M in shares, a negative signal for the healthcare conglomerate. Portfolio-level patterns include: (1) Growth portfolios outperforming legacy (BMS Growth +12% vs Legacy +1%; Gilead HIV +18% vs Veklury -69%), (2) Pricing pressure (Lilly realized prices -15%), and (3) Elevated R&D/SG&A growth (Gilead R&D +23%, SG&A +14%). Guidance updates are mixed: Lilly raised revenue but cut EPS, Merck and Baxter raised both, Stryker trimmed organic growth, and Gilead raised product sales but guided to a GAAP loss. The market implication is a continued rotation toward companies with visible pipeline catalysts and away from those facing patent cliffs and margin erosion.

5 high priority 6 medium 11 total filings
· daily

S&P 500 Technology Sector SEC Filings — October 28, 2026

Across the 12 filings for the S&P 500 Technology stream, the dominant theme is strong top-line momentum paired with a widening gap between GAAP and non-GAAP profitability. Cadence (revenue +22.0% YoY), Fortinet (revenue +20% YoY, billings +29%), KLA (revenue +28.9% YoY), ServiceNow (revenue +20.5% YoY) and Microsoft (revenue +19% YoY) all reported solid growth, but several growth figures were flattered by non-operating items: Microsoft's GAAP EPS growth of 32% compares with 18% non-GAAP, largely because other income swung from a $3.66B expense to a $38M gain. ServiceNow's GAAP operating income fell 32.7% YoY despite 20.5% revenue growth, as subscription cost of revenue rose 58.3%. Forward indicators are mixed: ServiceNow guided Q4 cRPO growth to 18.5% versus 20.5% in Q3, signaling deceleration, while Fortinet raised full-year revenue guidance to roughly 20% growth. Capital intensity is rising, with Microsoft's property and equipment capex more than doubling to $39.4B and KLA's quarterly capex rising to $195M from $89M. Insider activity was net positive, with Accenture's Chair and CEO buying roughly $2.7M of shares in aggregate and a director buying about $200K. Cash has been deployed heavily into M&A and buybacks, with Cadence paying $2.14B for business combinations and $800M in repurchases, and ServiceNow spending $9.17B on business combinations while long-term debt rose to $5.44B from $1.49B. Accenture's 'Chair and CEO' transaction data and the Oracle 8-K (where substantive figures sit in an unincluded exhibit) limit the depth of analysis for those names.

8 high priority 4 medium 12 total filings
· daily

Nasdaq 100 Stocks SEC Filings — October 28, 2026

Across the 12 filings, the NASDAQ-100 mega-cap cohort shows strong top-line momentum led by cloud and AI infrastructure: Alphabet reported revenue up 25% YoY with Google Cloud up 103%, Microsoft grew revenue 18.8% with Microsoft Cloud up 30%, and T-Mobile's Q3 revenue rose 7.4% with net income up 27.3%. Earnings quality is the common weak point: GAAP results at Microsoft and Alphabet were inflated or distorted by investment mark-to-market swings (Microsoft's other income swung from a $3,660M expense to $38M gain, and the OpenAI gain of $207M versus a $3.1B prior-year loss flatters the 32% GAAP EPS growth versus 18% non-GAAP; Alphabet's net income fell 25% as other expense of $8,221M replaced a $12,759M gain). Capital intensity is rising sharply: Microsoft's property and equipment capex more than doubled to $39,367M, while Alphabet's long-term debt jumped to $125,102M from $46,547M at year-end 2025 with $28.7B of senior notes and $12.4B of ATM equity issuance. Capital returns remain robust, with T-Mobile repurchasing $9,564M over nine months (up 27.1%) and ADP lifting treasury stock via $758.8M of buybacks. Insider selling at Meta and Intuitive Surgical was uniformly under Rule 10b5-1 plans and is best read as routine diversification rather than a conviction signal. Market implication: the market is rewarding revenue acceleration in AI and cloud but will increasingly scrutinize GAAP quality, financing needs, and free cash flow conversion.

9 high priority 3 medium 12 total filings